SCHEMBL2863245

SCHEMBL2863245

O=C(O)n1nc(-c2cccc(F)c2)c2cc(CO)ccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 3/20 0.43
FYN P06241 1/20 0.40
NR4A1 P22736 1/20 0.39
NR4A2 P43354 1/20 0.39
NR4A3 Q92570 1/20 0.39
PDE4B Q07343 2/20 0.38
ICMT O60725 2/20 0.38
HPN P05981 1/20 0.37
MAP2K4 P45985 1/20 0.37
KDM4E B2RXH2 2/20 0.37
PTGDR2 Q9Y5Y4 2/20 0.36
TBXA2R P21731 1/20 0.36
PTGDR Q13258 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CSNK1D P48730 1/20 0.36
CSNK1E P49674 1/20 0.36
MAPT P10636 1/20 0.35
ELANE P08246 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2859046 0.89 TAAR1 (0.46) PTGER1NR4A1NR4A2NR4A3PDE4B
SCHEMBL2864259 0.89 PTGER1 (0.43) PTGER1NR4A1NR4A2NR4A3PDE4B
SCHEMBL2871350 0.89 PTGER1 (0.43) PTGER1NR4A1NR4A2NR4A3PDE4B
SCHEMBL2858091 0.84 MAP2K4 (0.56) PTGER1FYNPDE4BICMTMAP2K4
SCHEMBL4327851 0.83 PTGER1 (0.45) PTGER1ICMTMAP2K4KDM4EPTGDR2
SCHEMBL6757088 0.82 PTGER1 (0.57) PTGER1KDM4EELANESMN1; SMN2
SCHEMBL2867293 0.81 PTGER1 (0.43) PTGER1ICMTMAP2K4KDM4EPTGDR2
SCHEMBL2862700 0.81 SRC (0.39) ICMTKDM4E
SCHEMBL2860687 0.79 L3MBTL1 (0.54) PTGER1MAPTELANESMN1; SMN2
SCHEMBL2860693 0.79 L3MBTL1 (0.54) PTGER1MAPTELANESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PTGER1 3143/4885FYN 235/4885NR4A1 728/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 PTGER1 4240/4885FYN 353/4885NR4A1 376/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PTGER1 3143/4885FYN 235/4885NR4A1 728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.